RESPIRATORY VIRAL PNEUMONIA PANEL II (20 PATHOGENS)

Respiratory Viral Pneumonia Panel II (20 Pathogens) is an advanced multiplex molecular diagnostic test designed to simultaneously detect 20 clinically significant respiratory pathogens associated with upper respiratory tract infections, lower respiratory tract infections, and viral pneumonia. Using highly sensitive PCR technology, this panel provides rapid identification of multiple respiratory viruses and atypical pathogens from a single patient sample.

Respiratory infections are among the leading causes of illness worldwide and often present with similar symptoms such as fever, cough, sore throat, nasal congestion, shortness of breath, chest discomfort, and pneumonia. Because multiple pathogens can cause similar clinical presentations, comprehensive pathogen testing is essential for accurate diagnosis and effective treatment planning.

Benefits of the Test

• Simultaneously detects 20 respiratory pathogens.
• Provides rapid and highly accurate molecular diagnosis.
• Identifies viral and atypical respiratory infections.
• Supports targeted clinical management.
• Reduces unnecessary antibiotic prescriptions.
• Helps diagnose viral pneumonia and severe respiratory illness.
• Supports infection control and outbreak surveillance.
• Improves patient outcomes through early detection.

Why Doctors Recommend This Test

Doctors recommend this test for patients with moderate to severe respiratory symptoms, suspected viral pneumonia, persistent fever, chronic cough, breathing difficulties, unexplained respiratory infections, hospitalized patients, and individuals at high risk of complications. The test is especially useful when rapid identification of the infectious agent is required.

Accurate pathogen identification helps clinicians determine appropriate antiviral, antibacterial, or supportive treatment strategies while improving overall patient care.

Preparation Before Test

• No fasting is required.
• Nasopharyngeal swab, throat swab, sputum, or respiratory specimen may be collected.
• Inform your doctor about any recent medications or treatments.
• Follow instructions provided by healthcare professionals.
• Ensure prompt sample collection during active symptoms whenever possible.
• Provide relevant medical history and recent travel or exposure information.

Normal Reporting Time

Most Respiratory Viral Pneumonia Panel II (20 Pathogens) reports at Focus Diagnostics are available within 2–3 hours after sample processing. Additional quality verification procedures may occasionally extend reporting times depending on laboratory requirements.

Who Should Take This Test?

This test may be recommended for:

• Patients with suspected viral pneumonia.
• Individuals with acute respiratory infections.
• People with severe flu-like symptoms.
• Hospitalized patients with respiratory illness.
• Children and elderly individuals.
• Immunocompromised patients.
• Patients with recurrent respiratory infections.
• Individuals requiring comprehensive respiratory pathogen screening.

Detailed Information

Respiratory Viral Pneumonia Panel II (20 Pathogens) is a comprehensive molecular diagnostic assay designed to identify a broad range of respiratory pathogens that commonly cause respiratory tract infections and pneumonia. Traditional diagnostic methods often require multiple separate tests and may take several days to provide results. Multiplex PCR technology significantly improves diagnostic efficiency by detecting multiple pathogens simultaneously from a single specimen.

The panel may include detection of Influenza A and B viruses, Respiratory Syncytial Virus (RSV), Adenovirus, Human Metapneumovirus, Rhinovirus, Enterovirus, Parainfluenza viruses, seasonal Coronaviruses, SARS-related respiratory viruses, and atypical bacterial pathogens such as Mycoplasma pneumoniae, Chlamydia pneumoniae, and Bordetella pertussis, depending on the specific assay configuration.

Rapid identification of respiratory pathogens is important because respiratory infections often present with overlapping symptoms. Clinical findings alone may not reliably distinguish between viral and bacterial causes. Accurate laboratory diagnosis allows healthcare providers to tailor treatment strategies, reduce inappropriate antibiotic usage, and implement effective infection prevention measures.

The test is especially beneficial during influenza seasons, respiratory virus outbreaks, and periods of increased community transmission of respiratory illnesses. Early diagnosis helps healthcare providers initiate appropriate therapies, monitor disease progression, and identify patients at risk of complications.

Patients with chronic lung disease, asthma, chronic obstructive pulmonary disease (COPD), cancer, immunosuppression, organ transplantation, and advanced age are particularly vulnerable to severe respiratory infections. Comprehensive pathogen detection supports improved clinical management and helps reduce morbidity associated with respiratory disease.

The panel is also valuable in healthcare settings for outbreak investigations, hospital infection control programs, emergency department evaluations, and intensive care unit management. By identifying the exact pathogen responsible for infection, clinicians can make evidence-based treatment decisions and optimize patient care.

At Focus Diagnostics, Respiratory Viral Pneumonia Panel II (20 Pathogens) testing is performed using advanced multiplex PCR platforms, stringent quality assurance standards, and state-of-the-art molecular diagnostic technology to provide highly accurate, reliable, and clinically meaningful results.